Cost-effectiveness of testosterone treatment utilising individual patient data from randomised controlled trials in men with low testosterone levels.

Rodolfo HernándezNipun Lakshitha de SilvaJemma HudsonMoira CruickshankRichard QuintonPaul MansonWaljit S DhilloSiladitya BhattacharyaMiriam BrazzelliChanna N Jayasena

Published in: Andrology (2024)

Our data suggest that testosterone is cost-effective in men <75 years when Beck depression index-derived quality-adjusted life years data are considered; cost-effectiveness in men >75 years is dependent on cardiovascular safety. However, more robust and longer-term cost-utility data are needed to verify our conclusion.

Keyphrases

electronic health record
big data
replacement therapy
middle aged
depressive symptoms
preterm infants
case report
machine learning
physical activity
quality improvement